LUKE M BESHAR
CIK 1192128 · EVP & CFO · last filed 2025-06-13
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$857.3K
Companies
5
Total Filings
66
Lifetime Open-Market Net
-$17.22M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| TARA | Director | 198,000 | $3.90 | $772.2K | $118.1K | 11 | 2025-06-13 |
| Omega Therapeutics, Inc. (OMGA) Delisted | Director | — | $0.14 | — | $0 | 3 | 2023-06-09 |
| RGNX | Director | 12,784 | $6.66 | $85.1K | -$4.18M | 11 | 2021-06-08 |
| NPS PHARMACEUTICALS INC (NPSP) Delisted | EVP & CFO | 0 | — | — | -$12.66M | 34 | 2015-02-24 |
| CAMBREX CORP (CBM) Delisted | Executive Vice President | 0 | — | — | -$497.0K | 6 | 2007-10-12 |
Recent Filings · Page 3 of 7
66 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2018-11-21 | RGNX | Mixed | — | -$1.53M | EDGAR |
| 2018-05-30 | RGNX | Grant (A) | — | $0 | EDGAR |
| 2017-05-26 | RGNX | Grant (A) | — | $0 | EDGAR |
| 2016-06-02 | RGNX | Grant (A) | — | $0 | EDGAR |
| 2015-09-22 | RGNX | Grant (A) | — | $0 | EDGAR |
| 2015-09-17 | RGNX | Grant (A) | — | $0 | EDGAR |
| 2015-02-24 | NPS PHARMACEUTICALS INC (NPSP) Delisted | Mixed | −75,201 | -$3.46M | EDGAR |
| 2015-02-20 | NPS PHARMACEUTICALS INC (NPSP) Delisted | Mixed | +21,388 | -$342.6K | EDGAR |
| 2015-02-09 | NPS PHARMACEUTICALS INC (NPSP) Delisted | Gift (G) | −10,000 | $0 | EDGAR |
| 2014-12-19 | NPS PHARMACEUTICALS INC (NPSP) Delisted | Mixed | — | -$1.46M | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.